Clinical Trial Update: Sulfonylurea Effects on Glucagon Regulation During Hypoglycemia in Type 1 DM [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial examining how sulfonylureas influence glucagon regulation during hypoglycemia in type 1 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Diabetes Mellitus, Type 1 | Phase 2, Phase 3 | Status: COMPLETED